Form 4: Photronics Director Walter M. Fiederowicz Acquires 3,108 Shares of Common Stock
SEC Form 4 Filing
Director Walter M. Fiederowicz increased his holdings in Photronics by acquiring 3,108 shares of common stock at a price of $22.52 per share on February 13, 2025.
Summary
- On February 13, 2025, Walter M. Fiederowicz, a director of Photronics Inc. (PLAB), acquired 3,108 shares of the company's common stock.
- The shares were purchased at a price of $22.52 per share.
- Following the transaction, Fiederowicz directly owns 35,108 shares of Photronics common stock.
- The acquisition was reported on a Form 4 filing with the Securities and Exchange Commission (SEC) on February 14, 2025.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The purchase of shares by a director is generally a good sign, but the impact is limited as it's a relatively small transaction.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Insider transactions are closely monitored by investors as they can provide insights into a company's prospects. A director's purchase is generally viewed more favorably than a sale.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 02/13/2025 | Date of transaction: Walter M. Fiederowicz acquired 3,108 shares of Photronics common stock. |
| 02/14/2025 | Date of Form 4 filing with the SEC. |
Keywords
Photronics, PLAB, Director, Stock Acquisition, Form 4, Insider Trading, Walter M. Fiederowicz, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.